Healthcare giant Novo Nordisk has partnered with Amazon Web Services (AWS) as its cloud provider to accelerate the discovery process of new treatments for chronic diseases and modernize its global operations. This strategic partnership aims to significantly reduce the time and cost of developing new drugs by combining biomedical expertise, advanced cloud infrastructure, and generative AI tools specifically designed for life sciences.

Joint Innovation Center Established in London

Seeking to overcome departmental gaps and operational delays in biopharmaceutical research, the two companies have established a dedicated Joint Innovation Center in King’s Cross, London. In this center, Novo Nordisk researchers, AWS engineers, and data scientists work side-by-side under one roof.

Thanks to this physical proximity, numerical modeling and laboratory tests enter an instant feedback loop. Molecular analyzes provided by artificial intelligence are instantly validated by researchers and converted into experimental parameters. Thus, the critical process from identifying the target molecule to administering the first clinical dose is significantly shortened.

AWS Technologies specifically for Life Sciences in Action

Novo Nordisk leverages AWS’s industry-specific advanced cloud and machine learning solutions to accelerate research and development processes.

Featured AI and Cloud Solutions

• Amazon Bio Discovery: This platform, directly accessible to researchers, automatically generates potential therapeutic molecules, visualizes their structures, and analyzes their properties. By linking digital design with lab testing, it accelerates early-stage discovery processes.

• Amazon Bedrock AgentCore: Enables the construction of intelligent AI agents that analyze complex datasets in enterprise repositories, execute multi-step workflows, and integrate with laboratory information management systems (LIMS).

• Secure and Scalable Cloud Infrastructure: Massive genomic, biological, and clinical datasets are centralized in a cloud environment fully compliant with global health regulatory standards and strict data privacy rules.

This toolset removes high-performance computing power from the monopoly of data scientists, making it directly accessible to over 66,000 employees in 80 countries and expanding the use of AI within the company.

Integrated Healthcare Vision with the Amazon Ecosystem

The collaboration between Novo Nordisk and Amazon is not limited to R&D. The company is already collaborating with Amazon Pharmacy, Amazon One Medical, and Amazon Ads in areas such as delivering, distributing, and managing contemporary treatments for patients.

The integration of AWS infrastructure into this structure enables the management of all processes, from R&D to production, supply chain to clinical operations, through a single digital backbone. This infrastructure, which respects information confidentiality, algorithmic transparency, and ethical standards, opens the door to the much faster development of more targeted treatments for major chronic diseases affecting millions of people.